NTI 1.85% 5.3¢ neurotech international limited

Ann: Last Patient Completes Treatment in NTIPANS1 Clinical Trial, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 628 Posts.
    lightbulb Created with Sketch. 137
    Totally agree with your comments. There is massive potential with these treatments, early signs are good, still a long way to go. This drug could help millions of people, particularly children. The bonus is...we as SH may also make a lot of money.

    Here's a chart from Next Investors who have just started covering NTI and have bought 8.4m shares themselves.https://hotcopper.com.au/data/attachments/5588/5588105-8dda160ea8329df1f3371dc3f411dbf2.jpg

 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
5.3¢
Change
-0.001(1.85%)
Mkt cap ! $54.83M
Open High Low Value Volume
5.4¢ 5.5¢ 5.3¢ $33.62K 629.5K

Buyers (Bids)

No. Vol. Price($)
12 3755572 5.3¢
 

Sellers (Offers)

Price($) Vol. No.
5.5¢ 120107 3
View Market Depth
Last trade - 14.27pm 08/11/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.